Trial intelligence / Profile preview

Oxaliplatin + 5FU + Leucovorin in Advanced Gastric Cancer

NCT00263354Phase 2Completed

Sponsor
Sanofi
Start
Oct 2003
Primary completion
Jul 2006
Modality
DNA Intercalators/Alkylators
01

Overview

A Phase 2 trial of oxaliplatin in gastric cancer (GC), sponsored by Sanofi. Started Oct 2003; status: completed.

02

Drugs

oxaliplatin
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT00263354.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00263354.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call